North Chicago-based AbbVie said Monday it has signed an agreement with the Trump administration to lower some drug prices and invest $100 billion domestically in exchange for an exemption from certain tariffs.
To access this post, you must purchase 1 Year Health News Illinois Subscription or 1 Year Group Subscription - Up to 5 Users.